Back

The role of fluorodeoxyglucose-positron emission tomography imaging in suspected inflammatory cardiomyopathy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Multimodal imaging in cardiac amyloidosis and cardiomyopathies Imaging HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Valentina Alice Rossi

University Hospital Zurich, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Prognostic value of right ventricular longitudinal strain in patients with transthyretin amyloid cardiomyopathy
Doctor E. Tan (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prognostic role of myocardial strain and its relationship with diffuse myocardial fibrosis accentuated by diabetes mellitus
Doctor S. Chadalavada (London, GB)
Abstract Slides Video
Presentation thumbnail
Left atrial strain has prognostic value in dilated cardiomyopathy patients with recovered ejection fraction
Mr M. Venner (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodal imaging in cardiac amyloidosis and cardiomyopathies

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Role of cardiac magnetic resonance, endomyocardial biopsy and cardiac-specific PET in the diagnosis of inflammatory cardiomyopathy
thumbnail
Congress Presentation
The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.
thumbnail
Congress Presentation
Prognostic implications of residual cardiac FDG uptake in stable cardiac sarcoidosis post-immunosuppressive therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources